The Next Therapeutic Challenge in HIV: Polypharmacy

With the adoption of combination antiretroviral therapy (ART), most HIV-infected individuals in care are on five or more medications and at risk of harm from polypharmacy, a risk that likely increases with number of medications, age, and physiologic frailty. Established harms of polypharmacy include...

Descripción completa

Detalles Bibliográficos
Autores principales: Edelman, E. Jennifer, Gordon, Kirsha S., Glover, Janis, McNicholl, Ian R., Fiellin, David A., Justice, Amy C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715685/
https://www.ncbi.nlm.nih.gov/pubmed/23740523
http://dx.doi.org/10.1007/s40266-013-0093-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715685/
https://www.ncbi.nlm.nih.gov/pubmed/23740523
http://dx.doi.org/10.1007/s40266-013-0093-9

Ejemplares similares